Detalles de la búsqueda
1.
Risk factors and time-trends of cytomegalovirus (CMV), syphilis, toxoplasmosis and viral hepatitis infection and seroprevalence in human immunodeficiency virus (HIV) infected patients
Annals of the Academy of Medicine, Singapore
; : 667-673, 2013.
Artículo
en Inglés
| WPRIM | ID: wpr-285576
2.
Infectious disease trends among immunocompromised hosts
Singapore medical journal
; : 223-quiz 230, 2012.
Artículo
en Inglés
| WPRIM | ID: wpr-334520
3.
Discovery of a 382-nt deletion during the early evolution of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-987222
4.
Identifying COVID-19 cases in primary care settings
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20182204
5.
Finger stick blood test to assess post vaccination SARS-CoV-2 neutralizing antibody response against variants
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21266241
6.
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20232835
7.
Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-477163
8.
Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-450293
9.
Neutralizing antibodies from early cases of SARS-CoV-2 infection offer cross-protection against the SARS-CoV-2 D614G variant.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-332544
10.
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-355107
Resultados
1 -
10
de 10
1
Próxima >
>>